semaglutide cardiac 2026 Update: is now an approved medication for cardiovascular diseases. It is recommended for the treatment of Type 2 diabetes and secondary prevention of cardiovascular complications in adults with established heart GLP-1 agonists like Ozempic may

Screening for other causes of constipation

How ROSE-010 Works in IBS: Targeted, On-Demand Pain Relief ROSE-010 mimics natural GLP-1 with an optimized, short-acting profile: Fast-acting ( Begins working in 20 minutes ) Short duration ( Clears in a few hours ) Use only when needed during acute episodes for pain resolution Clinical Validation: Proven IBS Pain Relief In Phase 2a Trial Results (Hellstrm et al.), ROSE-010 166 patients with IBS pain (placebo-controlled study) Twice as many patients responded to ROSE-010 vs

Really happy to see that and we will continue to follow our patients, continue to track their weight loss and continue to publish results as we get them

However, some meta-analyses suggest injectable semaglutide may produce slightly greater weight loss overall

Request a Certificate of Analysis